LEADER 00000cam  2200661Ii 4500 
001    ocn928883668 
003    OCoLC 
005    20161228020641.0 
006    m     o  d         
007    cr cnu|||unuuu 
008    151112s2015    ne      ob    001 0 eng d 
019    930041300|a962128888 
020    9789036809801|q(electronic bk.) 
020    9036809800|q(electronic bk.) 
020    |z9789036809795 
020    |z9036809797 
035    (OCoLC)928883668|z(OCoLC)930041300|z(OCoLC)962128888 
040    N$T|beng|erda|epn|cN$T|dIDEBK|dN$T|dYDXCP|dOCLCF|dGW5XE
       |dOHI|dCASUM|dIAO|dIAS|dIAD|dJBG|dSOI|dILO|dSTJ 
049    STJP 
050  4 QP187 
072  7 SCI|x007000|2bisacsh 
072  7 MED|x075000|2bisacsh 
072  7 SCI|x036000|2bisacsh 
082 04 612.4|223 
099    PHARM WORLD WIDE WEB|aE-BOOK|aSPRINGER 
100 1  Graaf, J. de|q(Jacqueline),|eauthor. 
245 10 ApoB in clinical care /|cJ. de Graaf, P. Couture and A.D. 
       Sniderman. 
264  1 Houten :|bSpringer,|c2015. 
300    1 online resource 
336    text|btxt|2rdacontent 
337    computer|bc|2rdamedia 
338    online resource|bcr|2rdacarrier 
504    Includes bibliographical references and index. 
505 0  1. The life history of ApoB lipoprotein particles -- 2. 
       Diagnosis of the ApoB dyslipoproteinemias: the ApoB 
       algorithm -- 3. The primary ApoB dyslipoproteinemias -- 4.
       Secondary ApoB dyslipoproteinemias -- 5. ApoB in 
       cardiovascular risk prediction -- 6. ApoB lipoprotein 
       particles: the preferred treatment target in primary and 
       secondary prevention -- 7. The future of ApoB: moving from
       the risk prediction paradigm to the casual exposure 
       paradigm. 
588 0  Online resource; title from PDF title page (EBSCO, viewed 
       November 25, 2015). 
650  0 Endocrinology. 
650  0 Lipoproteins. 
650  0 Clinical competence. 
650  0 Apolipoproteins. 
650  7 SCIENCE / Life Sciences / Biochemistry.|2bisacsh 
650  7 MEDICAL / Physiology.|2bisacsh 
650  7 SCIENCE / Life Sciences / Human Anatomy & Physiology.
       |2bisacsh 
650  7 Apolipoproteins.|2fast|0(OCoLC)fst00811438 
650  7 Clinical competence.|2fast|0(OCoLC)fst00864347 
650  7 Endocrinology.|2fast|0(OCoLC)fst00909749 
650  7 Lipoproteins.|2fast|0(OCoLC)fst00999403 
650 12 Dyslipidemias. 
650 22 Algorithms. 
650 22 Apolipoprotein B-100. 
650 22 Apolipoprotein B-48. 
650 22 Arteriosclerosis. 
700 1  Couture, P.|q(Patrick),|eauthor. 
700 1  Sniderman, A.,|eauthor. 
776 08 |cOriginal|z9036809797|z9789036809795|w(OCoLC)907652736 
994    C0|bSTJ